Mateusz Wierzbicki
Overview
Explore the profile of Mateusz Wierzbicki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gharibkandi N, Majkowska-Pilip A, Walczak R, Wierzbicki M, Bilewicz A
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769315
Apart from HER2-positive, triple-negative breast cancer (TNBC) is the second most highly invasive type of breast cancer. Although TNBC does not overexpress HER2 receptors, it has been observed that EGFR...
2.
Sosnowska M, Wierzbicki M, Nasilowska B, Bakalova T, Piotrowska K, Strojny-Cieslak B, et al.
Int J Nanomedicine
. 2024 Nov;
19:12221-12255.
PMID: 39600409
Introduction And Objective: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters the nasal cavity, penetrates the nasal epithelial cells through the interaction of its spike protein with the host cell...
3.
Kutwin M, Sosnowska-Lawnicka M, Nasilowska B, Lange A, Wierzbicki M, Jaworski S
Nanotechnol Sci Appl
. 2024 Sep;
17:167-188.
PMID: 39280996
Purpose: The use of nanotechnology in medicine has gained attention in developing drug delivery systems. GO has the potential to deliver microRNA (miRNA) mimics or antisense structures. MiRNAs regulate gene...
4.
Cymerys J, Bartak M, Slonska A, Lange A, Jaworski S, Chodkowski M, et al.
Int J Nanomedicine
. 2024 Sep;
19:9009-9033.
PMID: 39246425
Background: The high infectivity of coronaviruses has led to increased interest in developing new strategies to prevent virus spread. Silver nanoparticles (AgNPs) and graphene oxide (GO) have attracted much attention...
5.
Gharibkandi N, Wawrowicz K, Walczak R, Majkowska-Pilip A, Wierzbicki M, Bilewicz A
EJNMMI Radiopharm Chem
. 2024 Aug;
9(1):59.
PMID: 39136900
Background: Convenient therapeutic protocols for hepatocellular carcinoma (HCC) are often ineffective due to late diagnosis and high tumor heterogeneity, leading to poor long-term outcomes. However, recently performed studies suggest that...
6.
Hotowy A, Strojny-Cieslak B, Ostrowska A, Zielinska-Gorska M, Kutwin M, Wierzbicki M, et al.
Molecules
. 2024 Aug;
29(15).
PMID: 39124987
(1) Background: Angiotensin-converting enzyme 2 (ACE2) is a crucial functional receptor of the SARS-CoV-2 virus. Although the scale of infections is no longer at pandemic levels, there are still fatal...
7.
Wierzbicki M, Kot M, Lange A, Kalinska A, Golebiewski M, Jaworski S
Nanotechnol Sci Appl
. 2024 Mar;
17:77-94.
PMID: 38523648
Purpose: in dairy cows is a worldwide problem faced by dairy producers. Treatment mainly involves antibiotic therapy, however, due to widespread antibiotic resistance among bacteria, such treatments are no longer...
8.
Wojcik B, Zawadzka K, Sawosz E, Sosnowska M, Ostrowska A, Wierzbicki M
Nanotechnol Sci Appl
. 2023 Dec;
16:41-57.
PMID: 38111798
Introduction: Disorganisation of the extracellular matrix (ECM) is strongly connected to tumor progression. Even small-scale changes can significantly influence the adhesion and proliferation of cancer cells. Therefore, the use of...
9.
Sosnowska M, Kutwin M, Zawadzka K, Pruchniewski M, Strojny B, Bujalska Z, et al.
Cancers (Basel)
. 2023 Dec;
15(23).
PMID: 38067256
The epithelial-mesenchymal transition (EMT) is a process in which epithelial cells acquire the ability to actively migrate via a change to the mesenchymal phenotype. This mechanism occurs in an environment...
10.
Strojny-Cieslak B, Jaworski S, Wierzbicki M, Pruchniewski M, Sosnowska-Lawnicka M, Szczepaniak J, et al.
Environ Sci Pollut Res Int
. 2023 Oct;
31(60):67317-67338.
PMID: 37824053
The increasing emergence of antibiotic-resistant bacteria and the need to reduce the use of antibiotics call for the development of safe alternatives, such as silver nanoparticles. However, their potential cytotoxic...